• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, January 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Older breast cancer patients in England less likely to survive

Bioengineer by Bioengineer
June 7, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands according to research published today in the British Journal of Cancer*.

In one of the largest studies of its kind looking at breast cancer patients aged 70 and over, researchers found that England ranked worst out of the selected countries for five year survival for breast cancer at stage two and three.

The team based at the Leiden University Medical Centre in The Netherlands analysed the anonymised records of 236,015 women who'd been diagnosed with breast cancer before it had spread.

They also found patients with stage one or two breast cancer in England are most likely to have no surgery as part of their treatment compared with other countries.

Not having surgery at stage three was found to be linked to poorer survival. In England 44% of patients received no surgery at stage three, compared to 22% of patients in Belgium.

Overall the number of patients with stage three breast cancer surviving their disease for five years or more in England (48%) was 12% lower than in Belgium (60%).

Author Dr Marloes Derks said: "The fact breast cancer mortality in England is higher than in other countries in this study even for those women whose cancer is in its earliest stage suggests there is something more at play than just a failure to diagnose it early.

"We were surprised to see England had lower levels of breast cancer surgery and further research is needed to establish whether these two factors are linked."

Professor Arnie Purushotham, senior clinical adviser at Cancer Research UK, said: "We know that surgery is one of the most effective treatments for breast cancer so it's vital that women in England aren't missing out on surgical treatment that could save their lives.

"We need to better understand why patients in England are less likely to have surgery than their European counterparts. Surgery should be considered in all older patients who are fit to undergo this treatment.

"While the thought of an operation might sometimes be daunting, breakthroughs in surgical techniques have meant that for many patients a lumpectomy with minimal surgery to the armpit glands can be just as effective as more radical treatment."

###

Notes to editor:

*Derks et al. Variation in treatment and survival of older patients with nonmetastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group 10.1038/s41416-018-0090-1

Post embargo link: http://www.nature.com/articles/s41416-018-0090-1

Media Contact

Emily Attwood
[email protected]
020-346-96700
@CR_UK

http://www.cancerresearchuk.org

http://dx.doi.org/10.1038/s41416-018-0090-1

Share12Tweet8Share2ShareShareShare2

Related Posts

Derazantinib Boosts Gemcitabine by Blocking MUC5AC

December 30, 2025

FOCUS Study Reveals Insights on Melphalan for Uveal Melanoma

December 29, 2025

Black Grape Anthocyanins Boost 5-FU Cancer Therapy

December 29, 2025

Girdin Silencing Boosts Mebendazole’s Ovarian Cancer Fight

December 29, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    116 shares
    Share 46 Tweet 29
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    52 shares
    Share 21 Tweet 13
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Carotenoids Boost Rice Root Adaptation and Iron Uptake

Octave-Spanning Visible to SWIR Coil-Stabilized Brillouin Lasers

Electrically Tunable 2D Excitonic Metasurface Modulation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.